942 trials (keyword fallback)
Obesity · Sedentary
Primary: Neonatal Adiposity — 11.2; 12.4 % fat
Iron-deficiency · Pregnancy Anemia · Obesity
Primary: Recruitment Feasibility — 10 percentage eligible and enrolled
Diabetes Mellitus · Hypertension · Metabolic Disease
Primary: Change in BMI Standard Deviation Score — -0.12; -0.06 Standard Deviation Score — p=0.007
Chronic Kidney Disease · Cardiovascular Disease · Metabolic Syndrome
Primary: Change is Leptin to Adiponectin Ratio (LAR) — 2.2; 1.3; 1.3; 1.4 ng/micrograms
Maternal Death · Maternal Infections Affecting Fetus or Newborn · Neonatal SEPSIS
Primary: Maternal Death or Sepsis Within 6 Weeks (42 Days) Post-delivery in Intervention vs. Placebo Group. — 227; 344 Participants — p=<0.001
Obesity
Primary: Change in Body Mass Index Z-score — -0.01; 0.00; -0.04 Z-Score
Obesity · Obesity, Childhood · Obesity; Familial
Primary: Mother BMI — 30.6; 34.2; 34; 34.3 kg/m^2
Pediatric Obesity
Primary: Feasibility (Parents' Interest in the SBIRT.) — 84.3; NA; NA; NA percentage of parents
Obesity · Infertility
Primary: Luteinizing Hormone Pulse Amplitude — 2.73; 1.12 IU/L
Obesity
Primary: Change in Adult Body Mass Index — 0.3; -0.1 kg/m2 — p=0.67
Pregnancy
Primary: Changes in Maternal Ventilation During Labor Analgesia — 15.3; 12.6; 13.8 L/min
Maternal; Alcohol Use, Affecting Fetus
Primary: Urine Ethylglucuronide (EtG) Testing — 0 Participants
Pregnancy · Weight Gain
Primary: Gestational Weight Gain (GWG) — 12; 10 kg — p=0.01
Obesity, Childhood · Eating Behavior
Primary: Child Body Mass Index — 17.83; 18.78 kg/m-squred
Obesity
Primary: Body Weight — 99.8; 101.0 kilogram (kg) — p=0.001